E-LIB Suche - Ergebnisse für: Baryakh, E.

1

PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ..:

Zotina, E. ; Zhelnova, E. ; Karimova, E....
HemaSphere. 6 (2022) - p. 2156-2157 , 2022

Link: https://doi.org/10.1097/..

2

P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES O..:

Tolstykh, T. ; Baryakh, E. ; Ivanova, D....
HemaSphere. 6 (2022) - p. 1493-1494 , 2022

Link: https://doi.org/10.1097/..

3

PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEU..:

Kochneva, O. ; Baryakh, E. ; Misyurina, E....
HemaSphere. 6 (2022) - p. 1750-1751 , 2022

Link: https://doi.org/10.1097/..

4

P363: TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DURING COVI..:

Paramonova, E. ; Zhelnova, E. ; Misyurina, E....
HemaSphere. 6 (2022) - p. 263-264 , 2022

Link: https://doi.org/10.1097/..

5

PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICA..:

Grishina, E. ; Gagloeva, D. ; Zhelnova, E....
HemaSphere. 6 (2022) - p. 2054-2055 , 2022

Link: https://doi.org/10.1097/..

6

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENT..:

Polyakov, Y. ; Kaluzhskaya, K. ; Baryakh, E....
HemaSphere. 6 (2022) - p. 1480-1481 , 2022

Link: https://doi.org/10.1097/..

7

P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS ..:

Karimova, E. ; Zhelnova, E. ; Baryakh, E....
HemaSphere. 6 (2022) - p. 803-804 , 2022

Link: https://doi.org/10.1097/..

8

P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASS..:

Ivanova, D. ; Baryakh, E. ; Tolstykh, T....
HemaSphere. 6 (2022) - p. 1467-1468 , 2022

Link: https://doi.org/10.1097/..

9

PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATO..:

Kaluzskaya, K. ; Polyakov, Y. ; Baryakh, E....
HemaSphere. 6 (2022) - p. 2142-2143 , 2022

Link: https://doi.org/10.1097/..

10

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES ..:

Chudnova, T. ; Baryakh, E. ; Polyakov, Y....
HemaSphere. 6 (2022) - p. 1455-1456 , 2022

Link: https://doi.org/10.1097/..

11

PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID..:

Baryakh, E. ; Misyurina, E. ; Zhelnova, E....
HemaSphere. 6 (2022) - p. 1733-1734 , 2022

Link: https://doi.org/10.1097/..

12

BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED..:

Ionova, T. ; Andrievskikh, M. ; Amdiev, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

13

N-Terminal Fragment of Brain-Type Natriuretic Peptide (NT-p..:

Semochkin, S. V. ; Misyurina, E. N. ; Zhelnova, E. I....
Bulletin of Experimental Biology and Medicine. 167 (2019) 2 - p. 267-271 , 2019

Link: https://doi.org/10.1007/..

14

The role of translocations involving c-MYC/8q24, BCL2/18q21..:

Misyurina, A E ; Kravchenko, S K ; Kovrigina, A M...
Terapevticheskii arkhiv. 91 (2019) 7 - p. 52-62 , 2019

Link: https://doi.org/10.26442..

15

50 Efficacy of new short-term high intensive protocol BL-M-..:

Baryakh, E. ; Kravchenko, S. ; Zvonkov, E....
European Journal of Cancer Supplements. 8 (2010) 4 - p. 24 , 2010

Link: https://doi.org/10.1016/..